文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

左心发育不良综合征亚型与心室冠状动脉连接的多中心回顾性结局研究

Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study.
PubMed 文献 · Circulation · 2026-10-26

本研究为Fetal Heart Society多中心回顾性队列,纳入16中心591例活产并有意治疗的左心发育不良综合征(HLHS)患儿,按亚型及心室冠状动脉连接(VCCs)分层分析无移植生存(TFS)。中位随访9.0年,MS/AA伴VCCs者TFS最低(HR 1.69),胎儿超声诊断VCCs与更低TFS相关(HR 1.79),提示产前产后评估VCCs的预后价值。

要点

  • MS/AA伴VCCs的HLHS患儿无移植生存最低,10年TFS仅40.3%。
  • 胎儿超声怀疑VCCs的MS/AA患儿TFS显著低于无VCCs怀疑者(HR 1.79)。
  • MS/AA无VCCs者生存与MS/AS相似,MS/AA伴VCCs者Ⅰ期姑息手术类型与TFS无关。

核心结论

  • 在大规模多中心HLHS队列中,MS/AA亚型伴VCCs者的无移植生存最低。
  • 产前诊断VCCs与更低的TFS相关,强调出生前后评估VCCs的预后价值。

研究设计与样本

  • 多中心回顾性队列研究,纳入2012年1月至2016年12月Fetal Heart Society参与机构收治的<2月龄HLHS胎儿和婴儿。
  • 共16中心591例活产并有意治疗,收集临床与人口学数据,对MS/AA及疑似VCCs亚组复核胎儿和经胸超声心动图。
  • 采用Cox比例风险分析,控制中心(随机效应)、出生体重、遗传诊断、心外畸形及限制性/完整房间隔。

主要发现

  • MA/AA最常见(261例,44%),其次MS/AA(200例,34%)和MS/AS(130例,22%);MS/AA中115例(58%)疑似VCCs。
  • 中位随访9.0年(IQR 7.0-10.8),总TFS 5年55.6%、10年49.4%。
  • 以MS/AA无VCCs为参照,MS/AA伴VCCs的TFS最低(HR 1.69 [1.12, 2.57];5年44.7%,10年40.3%),其次为MA/AA(HR 1.40 [0.95, 2.05];5年54.1%,10年46.6%)。
  • MS/AA无VCCs(5年60.4%,10年56.9%)与MS/AS(HR 0.91 [0.59, 1.41];5年65.0%,10年58.3%)生存相似。
  • 产前诊断HLHS者(n=532)中,胎儿超声怀疑MS/AA伴VCCs者TFS低于无胎儿VCCs怀疑者(HR 1.79 [1.12, 2.85]);产后疑似VCCs的MS/AA病例中胎儿超声诊断VCCs 33/103(32%)。

临床怎么用

  • 对HLHS胎儿及新生儿应常规评估VCCs,尤其MS/AA亚型,以协助预后分层。
  • MS/AA伴VCCs者TFS较差,需加强围产期及术后随访管理。
  • Ⅰ期姑息手术类型的选择未显示影响MS/AA伴VCCs者的TFS。

局限性

  • 回顾性设计,VCCs依赖超声怀疑而非统一病理确认。
  • 胎儿超声仅诊断产后疑似VCCs病例中的32%,存在漏诊可能。
  • 仅纳入有意治疗的活产儿,未涵盖终止妊娠或死胎病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoplastic left heart syndrome (HLHS) is classified by anatomic subtype: mitral atresia and aortic atresia (MA/AA), mitral stenosis and aortic atresia (MS/AA), and mitral stenosis and aortic stenosis (MS/AS). The MS/AA subtype is associated with ventriculocoronary connections (VCCs). We assessed whether specific HLHS subtypes are associated with an increased risk of mortality and whether this risk is stratified by VCCs identified during fetal or postnatal echocardiography. We also assessed whether the type of neonatal intervention performed modified the risk. METHODS: We performed a multicenter retrospective cohort study of fetuses and infants <2 months old with HLHS who were admitted between January 2012 and December 2016 to participating Fetal Heart Society institutions. Clinical and demographic data were collected. Fetal and transthoracic echocardiograms from a subset of patients with MS/AA and those with suspected VCCs were reviewed. Cox proportional hazards analysis was performed, controlling for cardiac center (random effect), birth weight, genetic diagnosis, extracardiac malformation, and restricted/intact atrial septum. RESULTS: Among 16 centers, 591 patients were born alive with intention to treat. MA/AA was the most common subtype (261, 44%), followed by MS/AA (200, 34%) and MS/AS (130, 22%). Of those with MS/AA, 115 (58%) had suspected VCCs. Median follow-up was 9.0 (interquartile range: 7.0, 10.8) years. Overall transplant-free survival (TFS) was 55.6% at 5 years and 49.4% at 10 years. When comparing MA/AA, MS/AS, and MS/AA with and without VCCs (reference group: MS/AA without VCCs), MS/AA with VCCs had the lowest TFS (hazard ratio [HR], 1.69 [1.12, 2.57]; 5-year TFS, 44.7%; 10-year TFS, 40.3%). This was followed by MA/AA (HR, 1.40 [0.95, 2.05]; 5-year TFS, 54.1%; 10-year TFS, 46.6%). Survival of MS/AA without VCCs (5-year TFS, 60.4%; 10-year TFS, 56.9%) was similar to MS/AS (HR, 0.91 [0.59, 1.41]; 5-year TFS, 65.0%; 10-year TFS, 58.3%). Among those with a prenatal diagnosis of HLHS (n=532), patients with MS/AA and VCCs suspected on fetal echocardiogram had a lower TFS compared with those with MS/AA without fetal suspicion for VCCs (HR, 1.79 [1.12, 2.85]). Fetal echocardiography was used to diagnose VCCs in 33 of 103 (32%) cases with MS/AA and VCCs suspected postnatally. Of patients with MS/AA and VCCs, type of stage I palliation was not associated with TFS (P=0.784). CONCLUSIONS: In a large, multicenter cohort of HLHS patients, the MS/AA subtype with VCCs had the lowest TFS. Prenatal diagnosis of VCCs was associated with a lower TFS. This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Barris DM, Freud LR, Day PE, et al. Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study. Circulation. 2026. PMID: 42934200. doi:10.1161/CIRCULATIONAHA.126.080144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。